Invesaro

Stocks BLDR Financial statements

Financial statements

Builders FirstSource, Inc. financial statements

Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data Builders FirstSource, Inc. files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue6,3677,0347,7257,2808,55919,89422,72617,09716,40015,191
Cost of revenue4,7715,3075,8025,3046,33614,04314,98211,08511,01710,575
Gross profit1,5971,7271,9231,9772,2235,8517,7446,0125,3834,616
Selling, general and administrative1,3601,4421,5541,5851,6793,4643,9743,8363,7883,830
Operating income2362853693925442,3873,7702,1761,595786
Interest expense215193
Pre-tax income21.791.92612834082,2523,5721,9841,388512
Income tax-12353.155.660.994.652682244431077.2
Net income14438.82052223141,7252,7491,5411,078435
EBITDA3463784674926602,9354,2672,7352,1571,378
EPS, basic1.300.341.791.922.698.5516.9812.069.133.91
EPS, diluted1.270.341.761.902.668.4816.8211.949.063.89
Shares, basic (weighted)111113115116117202162128118111
Shares, diluted (weighted)114116117117118203163129119112

Balance sheet

FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Cash and equivalents14.457.510.114.142442.680.466.2154182
Receivables5696326546158231,7091,4481,4371,1631,061
Inventory5426025975617851,6261,4261,2281,2121,095
Other current assets34.833.643.939.158.9128124113117127
Total current assets1,2161,3961,3741,3072,2243,9683,4983,3013,1412,927
Property, plant and equipment6566396707227491,3851,5681,8041,9622,204
Lease right-of-use assets293275458486502594622
Goodwill7407407407697853,2703,4573,5573,6794,137
Intangible assets1591331031281201,6031,5511,2981,1041,184
Other non-current assets18.322.922.222.221.129.236.438104140
Total assets2,9103,0062,9323,2494,17410,71410,59510,49910,58311,238
Accounts payable4105144234376001,093803881868715
Accrued liabilities293272293309327719739718634566
Deferred revenue58.5216193163168168
Short-term debt12.515.613.927.33.666.363.653.4714.3
Total current liabilities7557987318211,0752,1291,8431,8631,7771,575
Long-term debt1,7721,5461,2771,5972,9782,9783,1773,7014,427
Lease liabilities237219375404434525548
Other non-current liabilities59.759.65952.280.4120138125135158
Total liabilities2,6002,6302,3362,4253,0215,9125,6335,7676,2876,885
Total debt1,7841,5611,2911,6242,9822,9843,1813,7044,441
Paid-in capital5285475605755894,2614,2584,2714,2714,197
Retained earnings-219-1723524956254070446024.1154
Shareholders' equity3103765968251,1534,8024,9634,7324,2964,352
Total equity3103765968251,1534,8024,9634,7324,2964,352
Total liabilities and equity2,9103,0062,9323,2494,17410,71410,59510,49910,58311,238
Shares outstanding112114115116117180139122114111

Cash flow statement

FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Net income14438.82052223141,7252,7491,5411,078435
Depreciation and amortization1109397.9100117547497558562591
Stock-based compensation10.513.514.412.21731.531.348.563.153.5
Deferred income tax-12549.151.85116.6-34.6-92.5-102-196.81
Change in receivables-44.6-75.7-9.2245.7-252-474381-24.1260182
Change in inventory-34-60.6-5.4344.2-220-28227223151.5199
Change in payables36.665.8-89.44.07161192-31475.8-28.6-167
Cash from operations1581792835042601,7443,5992,3071,8731,216
Capital expenditures-42.7-62.4-101-113-112-228-340-476-381-363
Acquisitions-3.97-92.9-32.6-1,206-628-239-336-1,123
Cash from investing-38.3-59.4-96.7-199-136-1,345-957-668-711-1,467
Debt issued750
Stock issued6.638.063.954.871.420.730.590.66
Share buybacks-1.09-2.64-4.9-10.4-4.15-1,715-2,593-1,812-1,517-414
Cash from financing-171-76-234-301286-780-2,604-1,653-1,075279
Net change in cash-50.643.1-47.43.97410-38137.8-14.387.528.1
Free cash flow1161161813911481,5163,2591,8311,492853
Interest paid197193108100111106169186188261
Income taxes paid2.885.643.1518.143.463393657937367.7

Key metrics

Worked out from the statements above. Latest values use the trailing twelve months to June 30, 2026; growth uses fiscal years. Valuation uses the share price of $59.17 on September 25, 2026.

Profitability

MetricValueHow it is calculated
Gross margin29.2%Gross profit / revenue.
Operating margin3.0%Operating income / revenue.
EBITDA margin7.1%EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin1.0%Pre-tax income / revenue.
Net margin0.7%Net income / revenue.
FCF margin4.4%Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin6.2%Cash from operations / revenue.
Effective tax rate30.7%Income tax / pre-tax income, when pre-tax income is positive.
Return on equity (ROE)2.6%Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)0.9%Net income / average total assets.
Return on invested capital (ROIC)3.5%Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
SG&A / revenue26.2%Selling, general and administrative expense / revenue.
Stock-based pay / revenue0.3%Stock-based compensation (from the cash flow statement) / revenue.
Capex / revenue1.8%Capital expenditures / revenue.
D&A / revenue4.1%Depreciation and amortization / revenue.

Growth

MetricValueHow it is calculated
Revenue growth, 1y-7.4%Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y-12.6%Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y12.2%Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Gross profit growth, 1y-14.3%Gross profit vs the same period a year earlier. Only from a positive base.
Gross profit CAGR, 3y-15.8%Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Gross profit CAGR, 5y15.7%Compound annual growth of gross profit over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating income growth, 1y-50.7%Operating income vs the same period a year earlier. Only from a positive base.
Operating income CAGR, 3y-40.7%Compound annual growth of operating income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating income CAGR, 5y7.7%Compound annual growth of operating income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EBITDA growth, 1y-36.1%EBITDA vs the same period a year earlier. Only from a positive base.
EBITDA CAGR, 3y-31.4%Compound annual growth of ebitda over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EBITDA CAGR, 5y15.8%Compound annual growth of ebitda over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Net income growth, 1y-59.6%Net income vs the same period a year earlier. Only from a positive base.
Net income CAGR, 3y-45.9%Compound annual growth of net income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Net income CAGR, 5y6.8%Compound annual growth of net income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EPS growth, 1y-57.1%EPS vs the same period a year earlier. Only from a positive base.
EPS CAGR, 3y-38.6%Compound annual growth of eps over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EPS CAGR, 5y7.9%Compound annual growth of eps over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating cash flow growth, 1y-35.1%Operating cash flow vs the same period a year earlier. Only from a positive base.
Operating cash flow CAGR, 3y-30.4%Compound annual growth of operating cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating cash flow CAGR, 5y36.1%Compound annual growth of operating cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Free cash flow growth, 1y-42.8%Free cash flow vs the same period a year earlier. Only from a positive base.
Free cash flow CAGR, 3y-36.0%Compound annual growth of free cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Free cash flow CAGR, 5y42.0%Compound annual growth of free cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Book value growth, 1y1.3%Book value vs the same period a year earlier. Only from a positive base.
Book value CAGR, 3y-4.3%Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value CAGR, 5y30.4%Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Total assets growth, 1y6.2%Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y2.0%Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y21.9%Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y-6.0%Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y-11.9%Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y-1.1%Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

MetricValueHow it is calculated
Current ratio1.79xCurrent assets / current liabilities.
Quick ratio0.75x(Cash + short-term investments + receivables) / current liabilities.
Cash ratio0.04x(Cash + short-term investments) / current liabilities.
Debt / equity1.15xTotal debt / shareholders' equity. Not shown when equity is negative.
Debt / assets40.5%Total debt / total assets.
Liabilities / assets64.6%Total liabilities / total assets.
Net debt$4.53BTotal debt - cash - short-term investments. Negative means more cash than debt.
Net debt / EBITDA4.38xNet debt / EBITDA (twelve months), when EBITDA is positive.
Working capital$1.43BCurrent assets - current liabilities.
Goodwill and intangibles / assets45.9%(Goodwill + intangible assets) / total assets.
Tangible book value-$1.19BShareholders' equity - goodwill - intangible assets.

Efficiency

MetricValueHow it is calculated
Asset turnover1.28xRevenue / average total assets.
Fixed asset turnover6.84xRevenue / average property, plant and equipment.
Inventory turnover8.04xCost of revenue / average inventory.
Days inventory45 days365 x average inventory / cost of revenue.
Receivables turnover11.1xRevenue / average receivables.
Days sales outstanding33 days365 x average receivables / revenue.
Days payables37 days365 x average accounts payable / cost of revenue.
Cash conversion cycle41 daysDays inventory + days sales outstanding - days payables.
FCF conversion623.4%Free cash flow / net income, when net income is positive.
Capex / operating cash flow28.8%Capital expenditures / cash from operations, when that is positive.

Per share

MetricValueHow it is calculated
EPS, diluted$0.95Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share$134.33Revenue / diluted weighted shares.
FCF per share$5.94Free cash flow / diluted weighted shares.
Operating cash flow per share$8.35Cash from operations / diluted weighted shares.
Book value per share$37.22Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Tangible book per share-$11.09Tangible book value / shares outstanding.
Cash per share$0.61(Cash + short-term investments) / shares outstanding.
Buybacks / FCF47.5%Share buybacks / free cash flow, when free cash flow is positive.

Valuation

MetricValueHow it is calculated
Market cap$6.37BShare price x shares outstanding.
Enterprise value$10.89BMarket cap + total debt - cash - short-term investments.
P/E62.1xMarket cap / net income. Only when net income is positive.
P/S0.44xMarket cap / revenue.
P/B1.59xMarket cap / shareholders' equity. Only when equity is positive.
P/FCF9.96xMarket cap / free cash flow. Only when free cash flow is positive.
P/OCF7.09xMarket cap / cash from operations, when positive.
EV/Sales0.75xEnterprise value / revenue.
EV/EBIT25.0xEnterprise value / operating income, when both are positive.
EV/EBITDA10.5xEnterprise value / EBITDA, when both are positive.
EV/FCF17.0xEnterprise value / free cash flow, when both are positive.
FCF yield10.0%Free cash flow / market cap.
Earnings yield1.6%Net income / market cap (the inverse of P/E).
Shareholder yield4.8%(Dividends paid + share buybacks) / market cap.
What was Builders FirstSource, Inc.'s revenue in fiscal 2025?

Builders FirstSource, Inc. reported revenue of $15.19B for fiscal 2025, 7.4% lower than the year before.

Was Builders FirstSource, Inc. profitable in fiscal 2025?

Yes. Net income was $435.2M, a net margin of 2.9%.

How much free cash flow did Builders FirstSource, Inc. generate in fiscal 2025?

Cash from operations of $1.22B minus capital expenditures of $362.6M left free cash flow of $853.3M.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to Builders FirstSource, Inc.